Upstream and Downstream Process Optimization is Essential to Cost Containment in Biologics Manufacturing

Improvements throughout the pipeline bring greater biologic yields, as well as higher quality. by Raymond E Peck, CEO of VxP Biologics Improvements throughout the pipeline bring greater biologic yields, as well as lower costs. Bioprocessing is the production of natural or genetically manipulated cells (or other organic parts). In the field of biologic pharmaceuticals, bioprocessing [...]

By |2018-04-05T13:01:46-04:00September 22nd, 2017|Analytical, Manufacturing|0 Comments

Vector Development

The creation, production and storage of viral vectors all pose highly unusual challenges. by Susan Thompson, Technical Director at VxP Biologics Traditional viral vaccines use attenuated or inactivated forms of viruses to trigger and “train” the body’s immune responses. In recent years, however, pharmaceutical developers have also begun to use viruses as vectors to deliver [...]

By |2018-02-07T09:34:35-05:00September 19th, 2017|Manufacturing|0 Comments
Go to Top